Avinger expands intellectual property portfolio

19 new u.s. and international patents issued and allowed in 2020 redwood city, ca / accesswire / january 19, 2021 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today provided an update on the expansion of its intellectual property portfolio in 2020. avinger announced the issuance and allowance of 10 new patents in the u.s. and 9 new patents in international markets in 2020, including 7 new patents related to its recently introduced tigereye™ image-guided cto crossing catheter.
AVGR Ratings Summary
AVGR Quant Ranking